jump to content jump to footer

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials and how a software solution for tumor assessment can improve the quality and reproducibility of data, all while saving time.

Moreover, such software solutions are a key aspect for the approval of novel drugs based on small sample size – like for example targeted or tissue agnostic medicine, as a significant advance for precision therapies. Dr. Tolcher describes how mint Lesion™ assists in generating trustworthy data, “so that [one] can ensure that the drugs that are getting approved really do work.”

Video Clinical Trials Standardized Reading Procedures Therapy Response Assessment Structured Reporting

Related Resources

Radiologist using mint Lesion for structured lung cancer screening reporting and AI-assisted lung nodule assessment
How mint Lesion supports radiologists in the German lung cancer screening program through structured reporting, AI-supported workflows, second reading, and longitudinal patient follow-up.
Lung Cancer Screening in Germany: How mint Lesion Supports Radiologists in Clinical Practice
A New Era of Early Detection — and New Challenges With the introduction of the nationwide lung cancer screening program starting in 2026,…
Radiologists working at workstations analyzing real CT images during an interactive RECIST workshop at ECR 2026
Insights into hands-on RECIST training at ECR 2026: interactive workshops, real cases, and structured reporting with mint Lesion
From Theory to Practice: Hands-On RECIST Training at ECR 2026
This year, Mint Medical contributed to multiple program highlights at the ECR 2026 - bringing together innovation, education, and real-world clinical…
Radiologists reviewing oncologic imaging cases during the ESOI–EORTC Workshop on standardized tumor response assessment
The ESOI–EORTC Workshop provides practical training in RECIST 1.1, standardized tumor response assessment, clinical trial imaging, and hands-on oncology case reviews.
ESOI–EORTC Workshop 2026: Experience, Exchange, and Standardized Tumor Response Assessment in Radiology
The ESOI–EORTC Workshop is one of the leading educational formats for radiologists focusing on the standardized assessment of tumor response.This…